Pricing

Adrestia Therapeutics

0 followers

‌

Adrestia Therapeutics are leaders in synthetic rescue, an approach that decodes the complexity of genetic networks to reveal new ways to treat diseases.

Industries

Biotechnology

Headquarters

Babraham, United Kingdom

Employees

11-50

Links

Org chart

Robert Johnson

Chief Executive Officer

Robert Johnson

Collapse

Dr. Yaron Galanty

Co-Founder and VP research/ Head of research

GABRIEL BALMUS

Co-Founder

Jane Whitrow

Interim Chief Operations Officer

John McGonigle

Director Of Bioinformatics

John Perry

Vice President of Human Genetics

Rafael E. Carazo Salas

Co-Founder and Consultant

Tom Heightman

Chief R&D Officer

Teams

+16

Research and Development Team

19 members

Leadership Team

10 members

Operations Team

3 members

Similar companies

Immunome

2 followers

Thermo Fisher Scientific

155 followers

BeiGene

19 followers

Cytiva

10 followers

WuXi Biologics

11 followers

Ascendis Pharma

8 followers

Fluency

35 followers

Amazentis

1 follower

Merck

211 followers

LuxPak Ltd

1 follower

Tessera Therapeutics

2 followers

Explore companies